Evidence map›Paper›PMID 40450241›Full record

ArticleBMC public health2025

The potentials of digital technology in social prescribing: a qualitative study of key stakeholders' perspectives.

Sima Rafiei, Mahsa Honary, Barbara Mezes

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Digital social prescribing: a concept analysis.Frontiers in public health · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sima RafieiDept. Management Science, Lancaster University Management School, Lancaster, UK.
Mahsa HonaryDept. Management Science, Lancaster University Management School, Lancaster, UK. m.honary1@lancaster.ac.uk.
Barbara MezesDepartment of Primary Care and Mental Health, University of Liverpool, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe automation and effective communication provided by technological facilities allow service providers to deliver social wellbeing activities in a prompt and cost-effective manner. This study explored the perspectives of social prescribers, coordinators, and community providers on the potential of digital technology in social prescribing and the challenges to its implementation.

methodsWe conducted a qualitative study and held three Focus Group Discussion (FGD) sessions with a sample of 18 stakeholders in the Northwest of England, UK including social prescribing coordinators, social prescribers, and voluntary, community, faith, and social enterprise (VCFSE) sector providers

resultsEight themes were identified regarding the potentials and challenges of digital social prescribing from the study participants' viewpoints. The main themes highlighting advantages include capacity and resource management, coordination and integration of support services, access and equity, and outcome evaluation. The challenges identified are digital illiteracy, awareness concerns, financial matters, and a lack of evidence.

conclusionsOur findings confirm that digital social prescribing offers significant potential to improve accessibility, time efficiency, and personalization in service delivery. However, they also underscore critical challenges, including technical barriers, financial constraints, and a lack of digital literacy among users and providers. Stakeholders emphasized that while digital SP can streamline referrals and enhance data sharing, its success depends on addressing inequalities in access to technology.

Indexed as

Digital TechnologySocial PrescribingStakeholder ParticipationEnglandFemaleFocus GroupsHumansMaleQualitative ResearchAdvantagesChallengesDigitalisationInformation technologySocial prescribing

Identifiers

PMID40450241
PMCPMC12125895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.